Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;44(9):1831-1839.
doi: 10.1007/s00449-021-02563-1. Epub 2021 Apr 5.

Dual effects of hypoxia on proliferation and osteogenic differentiation of mouse clonal mesenchymal stem cells

Hyoungki Kim  1   2 , Soonjo Kwon  3   4
Affiliations

Dual effects of hypoxia on proliferation and osteogenic differentiation of mouse clonal mesenchymal stem cells

Hyoungki Kim et al. Bioprocess Biosyst Eng. 2021 Sep.

Abstract

Mouse clonal mesenchymal stem cells (mc-MSCs) were cultured on a Cytodex 3 microcarrier in a spinner flask for a suspension culture under hypoxia condition to increase mass productivity. The hypoxia environment was established using 4.0 mM Na2SO3 with 10 μM or 100 µM CoCl2 for 24 h in a low glucose DMEM medium. As a result, the proliferation of mc-MSCs under hypoxic conditions was 1.56 times faster than the control group over 7 days. The gene expression of HIF-1a and VEGFA increased 4.62 fold and 2.07 fold, respectively. Furthermore, the gene expression of ALP, RUNX2, COL1A, and osteocalcin increased significantly by 9.55, 1.55, 2.29, and 2.53 times, respectively. In contrast, the expression of adipogenic differentiation markers, such as PPAR-γ and FABP4, decreased. These results show that the hypoxia environment produced by these chemicals in a suspension culture increases the proliferation of mc-MSCs and promotes the osteogenic differentiation of mc-MSCs.

Keywords: Differentiation; Hypoxia; Mesenchymal stem cells; Microcarrier culture; Proliferation.

PubMed Disclaimer

References

    1. Munir H, McGettrick HM (2015) Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev 24:2091–2100. https://doi.org/10.1089/scd.2015.0008 - DOI - PubMed
    1. Smaldone MC, Chancellor MB (2008) Muscle derived stem cell therapy for stress urinary incontinence. World J Urol 26:327–332. https://doi.org/10.1007/s00345-008-0269-9 - DOI - PubMed
    1. Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA (2018) Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering. Stem Cells Int. https://doi.org/10.1155/2018/8031718 - DOI - PubMed - PMC
    1. Eibes G, dos Santos F, Andrade PZ et al (2010) Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146:194–197. https://doi.org/10.1016/j.jbiotec.2010.02.015 - DOI - PubMed
    1. Zhou L, Kong J, Zhuang Y et al (2013) Ex vivo expansion of bone marrow mesenchymal stem cells using microcarrier beads in a stirred bioreactor. Biotechnol Bioprocess Eng 18:173–184. https://doi.org/10.1007/s12257-012-0512-5 - DOI

Substances

LinkOut - more resources